Effectiveness of low-dose lovastatin combined with low-dose colestipol in moderate to severe primary hypercholesterolaemia

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 53, Issue 5, 1993, Pages 457-463

  Tonstad, S ^a   Ose, L ^a   Gorbitz C ^a   Harrison, E M ^b   De Koning Gans, H J ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Upjohn   (Belgium)

Author keywords

Apolipoproteins; Colestipol; Hyperlipoproteinaemia; Lipoprotein (a); Lovastatin; Treatment response

Indexed keywords

COLESTIPOL; LIPOPROTEIN; MEVINOLIN;

ADULT; ARTICLE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADULT; AGED; CHOLESTEROL; COLESTIPOL; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; MIDDLE AGE;

EID: 0027320686     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519309092540     Document Type: Article

References (26)

1. The recognition and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society
2. LDL receptor defect in familial hypercholesterolemia
3. Multifactorial etiology of hypercholesterolemia
4. Lovastatin, nicotinic acid, and rhabdomylolysis
5. Myopathy and rhabdomylolysis associated with lovastatingemfibrozil combination therapy
6. The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
7. Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol
8. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia
9. Expanded clinical evaluation of lovastatin (EXCEL) study results
10. Immuno-turbidimetric determination of apolipoproteins A-l and B in serum
11. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifugation
12. Treatment of hypercholesterolemia by interference with bile acid metabolism
13. Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia
14. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia
15. Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia
16. Treatment of heterozygous familial hypercholesterolemia with lipid lowering drugs
17. Influence of combined therapy with mevinolin and interruption of bile-acid reabsorption on low density lipoproteins in heterozygous familial hypercholes terolemia
18. Effects of simvastatin and cholestyramine in familial and nonfamilial hyper-cholesterolemia
19. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia
20. Effectiveness of low-dose lovastatin in lowering serum cholesterol
21. Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin
22. Efficacy and long-term adverse effect pattern of lovastatin
23. Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemia
24. The natural history of medication compliance in a drug trial: limitations of pill counts
25. Accuracy of weighed dietary records in studies of diet and health
26. Saturated fats cholesterol and dietary compliance